Kamilla Begtrup
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant-level meta-analysis of the ONWARDS 1-5 trials.
Journal: Diabetes, obesity & metabolism
Published: February 12, 2024
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes.
Journal: Diabetes, obesity & metabolism
Published: July 04, 2022
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Journal: The New England journal of medicine
Published: September 22, 2020
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: November 07, 2019
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: November 28, 2018
Methodological concerns with the meta-analysis comparing insulin degludec/liraglutide and insulin glargine/lixisenatide.
Journal: Expert opinion on pharmacotherapy
Published: February 24, 2018
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
Journal: Diabetes technology & therapeutics
Published: March 11, 2017
Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 07, 2017
Is the ICH score a valid predictor of mortality in intracerebral hemorrhage?
Journal: Journal of the American Association of Nurse Practitioners
Published: September 24, 2013
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes.
Journal: Diabetes care
Published: January 24, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026